Authorizes the administration of the mpox vaccine by a pharmacist or a certified nurse practitioner.
This bill amends the Education Law to expand the authority of licensed pharmacists and certified nurse practitioners to administer immunizations through patient-specific orders or non-patient-specific regimens. It expressly adds the mpox vaccine to the list of vaccines that may be administered under existing pharmacist and certified nurse practitioner authority, alongside influenza, pneumococcal disease, shingles, hepatitis A and B, HPV, measles, mumps, rubella, varicella, COVID-19, meningococcal disease, tetanus, diphtheria, and pertussis, as well as medications needed for emergency treatment of anaphylaxis.
The bill also preserves and broadens the framework for administering other CDC-recommended immunizations to adults when the Commissioner of Health, in consultation with the education commissioner, determines the vaccine can be safely administered by a pharmacist and is needed to prevent the spread of a reportable communicable disease in New York, or when the vaccine is recommended for adults who meet age requirements, lack documentation or evidence of prior infection, or have another risk factor or indication. It further allows the Commissioner of Health to issue a statewide non-patient-specific regimen during an outbreak or imminent threat of outbreak. The act takes effect immediately.
The bill would amend sections of the Education Law governing pharmacist and certified nurse practitioner immunization authority, making mpox vaccination explicitly available through these providers and reaffirming their ability to administer a broader set of vaccines under specified conditions. It does not authorize unlicensed persons to give vaccines, but it does expand the practical scope of immunization services that pharmacists and certified nurse practitioners may provide to eligible patients, especially adults and, for influenza, children age two and older. The measure would also reinforce the Department of Health’s role in determining when additional vaccines may be administered and in issuing statewide regimens during outbreaks.
The available voting record shows strong bipartisan support and little opposition. The bill passed the Assembly Higher Education Committee unanimously, advanced unanimously through the Assembly Rules Committee, and passed the Assembly floor by a wide margin of 143-2. No committee transcript opposition is provided, and the vote pattern suggests the bill was viewed as a routine public health and access-to-care measure rather than a controversial policy change.
The main policy issue is the expansion of vaccine administration authority to pharmacists and certified nurse practitioners, particularly the addition of mpox vaccination and the continued use of non-patient-specific regimens. Supporters appear to favor improving access to immunizations and enabling quicker public health responses, especially during outbreaks or when a disease is prevalent. Any potential concerns would likely center on scope-of-practice boundaries, clinical safety, and the extent of commissioner discretion in authorizing additional vaccines, but the recorded votes indicate these concerns did not generate significant opposition in the Assembly.